Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

April 3, 2023

Study Completion Date

April 3, 2023

Conditions

Upper Respiratory Tract InfectionLower Respiratory InfectionSkin InfectionSubcutaneous Tissues InfectionGenital Infection

Interventions

DRUG

"test product (T) azithromycin capsule and reference product (R) azithromycin capsule Sumamed®"

Take one capsule orally every cycle(T or R)

Trial Locations (1)

Peking University People's Hospital, Beijing

All Listed Sponsors

lead

Peking University People's Hospital

OTHER